Eargo jumps 77% following FDA rule on OTC hearing aids

Aug. 16, 2022 5:26 PM ETEargo, Inc. (EAR)By: Jonathan Block, SA News Editor12 Comments

Human life with a hearing aid. Young man with a hearing aid behind the ear in a noisy city hears people around well

peakSTOCK/iStock via Getty Images

  • Microcap Eargo (NASDAQ:EAR) closed up 77% on Tuesday following the U.S. FDA's announcement that it would allow the sale of some hearing aids over the counter beginning in October.
  • Average daily volume for the company is ~4.2M shares. ~31.8M shares traded hands on Tuesday.
  • Seeking Alpha's Quant Rating views Eargo (EAR) as a strong sell.

Recommended For You

Comments (12)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.